恩典生命科技（02112）于2026年5月4日发布截至2026年4月30日的月报表。公告显示，公司本月未有新增股份发行、购回或注销活动，股本结构保持不变。
根据报告，恩典生命科技目前法定注册股本为3,000,000,000股，每股面值HKD 0.01，注册股本总额HKD 30,000,000。截至4月末，已发行股份总数维持在1,500,000,000股，库存股份为0股。公司披露当月并未进行任何期权行使或股权激励计划变动，仅保留“2013年4月12日采纳的购股权计划”可供后续行使，其对应拟发行或转让上限为150,000,000股。
公司同时确认已遵守香港联交所《上市规则》及相关法律规定。根据公告信息，本次报告由公司秘书陈坤签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.